Rottendorf Pharma
Markus Falkenstein's work experience begins in 2017 as an Apotheker at Apotheke am Schauspielhaus in Bochum. In October 2017, they started their position as a Doktorand at Heinrich-Heine-Universität Düsseldorf and held that role until June 2021. From July to December 2021, Markus worked as a Wissenschaftlicher Mitarbeiter (Postdoktorand) at the same university. In January 2022, they began working at Rottendorf Pharma as a Project Manager for Product Development, a position they currently hold.
Markus Falkenstein completed their Staatsexamen in Pharmazie at the University of Düsseldorf from 2012 to 2016. Following this, they pursued a Doctor's Degree in Medizinische und pharmazeutische Chemie at the same university from 2017 to 2021.
Rottendorf Pharma
1 followers
A first-class contract development and manufacturing organization (CDMO), Rottendorf Pharma has been manufacturing, packaging, developing formulations and analytical methods for solid oral dosage forms for the global pharmaceutical industry for more than 85 years. The company produces more than 600 originator and generic drug products annually for big, small, virtual, and global pharmaceutical and biotechnology companies. Rottendorf Pharma operates by the philosophy of Total Process Ownership (TPO) and Total Technological Mastering (TTM), in which we work as an extension of clients' organizations. Therefore leveraging our expertise to optimize solid dosage form production for our customers' benefit. Rottendorf Pharma has neither their own product brands in the market nor holds any product licenses, and therefore is never in competition with their clients.